Evaluation of Pyrazolone-Based Hydrazones as Potential Therapeutic Agents Against Glioblastoma.
- DOI
- 10.3390/ph19091335
- Published
- 2026 Aug 24
- Container
- Pharmaceuticals (Basel, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/ph19091335,
title = {Evaluation of Pyrazolone-Based Hydrazones as Potential Therapeutic Agents Against Glioblastoma.},
author = {Cameli G and Piergentili A and Spinozzi E and Tombesi A and Petrelli R and Cappellacci L and Morelli MB},
year = {2026},
journal = {Pharmaceuticals (Basel, Switzerland)},
doi = {10.3390/ph19091335},
url = {https://doi.org/10.3390/ph19091335}
}RIS
TY - JOUR TI - Evaluation of Pyrazolone-Based Hydrazones as Potential Therapeutic Agents Against Glioblastoma. AU - Cameli G AU - Piergentili A AU - Spinozzi E AU - Tombesi A AU - Petrelli R AU - Cappellacci L AU - Morelli MB PY - 2026 JO - Pharmaceuticals (Basel, Switzerland) DO - 10.3390/ph19091335 UR - https://doi.org/10.3390/ph19091335 ER -
APA
G, C., A, P., E, S., A, T., R, P., L, C., & MB, M. (2026). Evaluation of Pyrazolone-Based Hydrazones as Potential Therapeutic Agents Against Glioblastoma.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091335